Cargando…

Incorporation of tryptophan analogues into the lantibiotic nisin

Lantibiotics are posttranslationally modified peptides with efficient inhibitory activity against various Gram-positive bacteria. In addition to the original modifications, incorporation of non-canonical amino acids can render new properties and functions to lantibiotics. Nisin is the most studied l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Liang, Shao, Jinfeng, Li, Qian, van Heel, Auke J., de Vries, Marcel P., Broos, Jaap, Kuipers, Oscar P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833812/
https://www.ncbi.nlm.nih.gov/pubmed/26872656
http://dx.doi.org/10.1007/s00726-016-2186-3
_version_ 1782427387270529024
author Zhou, Liang
Shao, Jinfeng
Li, Qian
van Heel, Auke J.
de Vries, Marcel P.
Broos, Jaap
Kuipers, Oscar P.
author_facet Zhou, Liang
Shao, Jinfeng
Li, Qian
van Heel, Auke J.
de Vries, Marcel P.
Broos, Jaap
Kuipers, Oscar P.
author_sort Zhou, Liang
collection PubMed
description Lantibiotics are posttranslationally modified peptides with efficient inhibitory activity against various Gram-positive bacteria. In addition to the original modifications, incorporation of non-canonical amino acids can render new properties and functions to lantibiotics. Nisin is the most studied lantibiotic and contains no tryptophan residues. In this study, a system was constructed to incorporate tryptophan analogues into nisin, which included the modification machinery (NisBTC) and the overexpression of tryptophanyl-tRNA synthetase (TrpRS). Tryptophan and three different tryptophan analogues (5-fluoroTrp (5FW), 5-hydroxyTrp (5HW) and 5-methylTrp (5MeW)) were successfully incorporated at four different positions of nisin (I1W, I4W, M17W and V32W). The incorporation efficiency of tryptophan analogues into mutants I1W, M17W and V32W was over 97 %, while the mutant I4W showed relatively low incorporation efficiency (69–93 %). The variants with 5FW showed relatively higher production yield, while 5MeW-containing variants showed the lowest yield. The dehydration efficiency of serines or threonines was affected by the tryptophan mutants of I4W and V32W. The affinity of the peptides for the cation-ion exchange and reverse phase chromatography columns was significantly reduced when 5HW was incorporated. The antimicrobial activity of IIW and its 5FW analogue both decreased two times compared to that of nisin, while that of its 5HW analogue decreased four times. The 5FW analogue of I4W also showed two times decreased activity than nisin. However, the mutant M17W and its 5HW analogue both showed 32 times reduced activity relative to that of nisin.
format Online
Article
Text
id pubmed-4833812
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-48338122016-04-25 Incorporation of tryptophan analogues into the lantibiotic nisin Zhou, Liang Shao, Jinfeng Li, Qian van Heel, Auke J. de Vries, Marcel P. Broos, Jaap Kuipers, Oscar P. Amino Acids Original Article Lantibiotics are posttranslationally modified peptides with efficient inhibitory activity against various Gram-positive bacteria. In addition to the original modifications, incorporation of non-canonical amino acids can render new properties and functions to lantibiotics. Nisin is the most studied lantibiotic and contains no tryptophan residues. In this study, a system was constructed to incorporate tryptophan analogues into nisin, which included the modification machinery (NisBTC) and the overexpression of tryptophanyl-tRNA synthetase (TrpRS). Tryptophan and three different tryptophan analogues (5-fluoroTrp (5FW), 5-hydroxyTrp (5HW) and 5-methylTrp (5MeW)) were successfully incorporated at four different positions of nisin (I1W, I4W, M17W and V32W). The incorporation efficiency of tryptophan analogues into mutants I1W, M17W and V32W was over 97 %, while the mutant I4W showed relatively low incorporation efficiency (69–93 %). The variants with 5FW showed relatively higher production yield, while 5MeW-containing variants showed the lowest yield. The dehydration efficiency of serines or threonines was affected by the tryptophan mutants of I4W and V32W. The affinity of the peptides for the cation-ion exchange and reverse phase chromatography columns was significantly reduced when 5HW was incorporated. The antimicrobial activity of IIW and its 5FW analogue both decreased two times compared to that of nisin, while that of its 5HW analogue decreased four times. The 5FW analogue of I4W also showed two times decreased activity than nisin. However, the mutant M17W and its 5HW analogue both showed 32 times reduced activity relative to that of nisin. Springer Vienna 2016-02-12 2016 /pmc/articles/PMC4833812/ /pubmed/26872656 http://dx.doi.org/10.1007/s00726-016-2186-3 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Zhou, Liang
Shao, Jinfeng
Li, Qian
van Heel, Auke J.
de Vries, Marcel P.
Broos, Jaap
Kuipers, Oscar P.
Incorporation of tryptophan analogues into the lantibiotic nisin
title Incorporation of tryptophan analogues into the lantibiotic nisin
title_full Incorporation of tryptophan analogues into the lantibiotic nisin
title_fullStr Incorporation of tryptophan analogues into the lantibiotic nisin
title_full_unstemmed Incorporation of tryptophan analogues into the lantibiotic nisin
title_short Incorporation of tryptophan analogues into the lantibiotic nisin
title_sort incorporation of tryptophan analogues into the lantibiotic nisin
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833812/
https://www.ncbi.nlm.nih.gov/pubmed/26872656
http://dx.doi.org/10.1007/s00726-016-2186-3
work_keys_str_mv AT zhouliang incorporationoftryptophananaloguesintothelantibioticnisin
AT shaojinfeng incorporationoftryptophananaloguesintothelantibioticnisin
AT liqian incorporationoftryptophananaloguesintothelantibioticnisin
AT vanheelaukej incorporationoftryptophananaloguesintothelantibioticnisin
AT devriesmarcelp incorporationoftryptophananaloguesintothelantibioticnisin
AT broosjaap incorporationoftryptophananaloguesintothelantibioticnisin
AT kuipersoscarp incorporationoftryptophananaloguesintothelantibioticnisin